Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology
Halifax Health in Florida has become the first in the U.S. to treat cancer patients using the Accuray Radixact® System with VitalHold™ technology. This advanced system, housed at the Cancer Center for Hope – Port Orange, combines ClearRT® helical CT imaging and Synchrony® real-time adaptive delivery technologies to enhance precision in radiation delivery.
The VitalHold feature incorporates a fully integrated and automated surface-guided radiotherapy (SGRT) solution from C-RAD, offering benefits such as highly accurate patient positioning and enabling deep inspiration breath hold (DIBH) treatments. This technology aims to minimize radiation dose to organs at risk and supports tattoo-free positioning for improved patient comfort.
The implementation of this system demonstrates Halifax Health's commitment to providing cutting-edge cancer care to the Volusia County community, potentially improving treatment outcomes and patient quality of life.
Halifax Health in Florida è diventato il primo negli Stati Uniti a trattare pazienti affetti da cancro utilizzando il Sistema Accuray Radixact® con tecnologia VitalHold™. Questo sistema avanzato, situato presso il Cancer Center for Hope – Port Orange, combina imaging CT elicoidale ClearRT® e tecnologie di consegna adattive in tempo reale Synchrony® per migliorare la precisione nella somministrazione della radioterapia.
La funzione VitalHold integra una soluzione di radioterapia guidata dalla superficie (SGRT) completamente automatizzata di C-RAD, che offre vantaggi come il posizionamento del paziente estremamente accurato e consente trattamenti di trattenimento del respiro a profonda inspirazione (DIBH). Questa tecnologia mira a minimizzare la dose di radiazione agli organi a rischio e supporta un posizionamento senza tatuaggi per un maggiore comfort del paziente.
L'implementazione di questo sistema dimostra l'impegno di Halifax Health nel fornire cure oncologiche all'avanguardia alla comunità della Contea di Volusia, con potenziali miglioramenti negli esiti dei trattamenti e nella qualità della vita dei pazienti.
Halifax Health en Florida se ha convertido en el primero en los EE. UU. en tratar pacientes con cáncer utilizando el Sistema Accuray Radixact® con tecnología VitalHold™. Este sistema avanzado, ubicado en el Cancer Center for Hope – Port Orange, combina imágenes CT helicoidales ClearRT® y tecnologías de entrega adaptativa en tiempo real Synchrony® para mejorar la precisión en la administración de radioterapia.
La función VitalHold incorpora una solución de radioterapia guiada por la superficie (SGRT) completamente integrada y automatizada de C-RAD, ofreciendo beneficios como un posicionamiento del paciente altamente preciso y permitiendo tratamientos de sostenimiento de la respiración en inspiración profunda (DIBH). Esta tecnología busca minimizar la dosis de radiación a los órganos en riesgo y apoya un posicionamiento sin tatuajes para mejorar la comodidad del paciente.
La implementación de este sistema demuestra el compromiso de Halifax Health en proporcionar atención oncológica de vanguardia a la comunidad del Condado de Volusia, mejorando potencialmente los resultados de los tratamientos y la calidad de vida de los pacientes.
플로리다에 위치한 Halifax Health는 미국에서 Accuray Radixact® 시스템과 VitalHold™ 기술를 사용하여 암 환자를 치료하는 첫 번째 병원이 되었습니다. 이 첨단 시스템은 Cancer Center for Hope – Port Orange에 위치하고 있으며, ClearRT® 나선형 CT 이미지와 Synchrony® 실시간 적응형 전달 기술을 결합하여 방사선 전달의 정확성을 향상시킵니다.
VitalHold 기능은 C-RAD의 완전 통합 및 자동화된 표면 유도 방사선 치료(SGRT) 솔루션을 포함하여 매우 정확한 환자 위치를 제공하고 깊은 호흡 유지를 위한 치료(DIBH)를 가능하게 합니다. 이 기술은 위험에 처한 장기로의 방사선량을 최소화하고 환자의 편안함을 개선하기 위해 타투 없는 포지셔닝을 지원합니다.
이 시스템의 구현은 Halifax Health가 Volusia 카운티 공동체에 최첨단 암 치료를 제공하겠다는 의지를 보여주며, 치료 결과와 환자의 삶의 질을 향상시킬 잠재력을 가지고 있습니다.
Halifax Health en Floride est devenu le premier aux États-Unis à traiter des patients atteints de cancer en utilisant le Système Accuray Radixact® avec la technologie VitalHold™. Ce système avancé, situé au Cancer Center for Hope – Port Orange, combine l'imagerie CT hélicoïdale ClearRT® et les technologies de délivrance adaptative en temps réel Synchrony® pour améliorer la précision dans l'administration de la radiothérapie.
La fonctionnalité VitalHold intègre une solution de radiothérapie guidée par la surface (SGRT) entièrement intégrée et automatisée de C-RAD, offrant des avantages tels qu'un positionnement des patients hautement précis et permettant des traitements de maintien de la respiration en profonde inspiration (DIBH). Cette technologie vise à minimiser la dose de radiations aux organes à risque et soutient un positionnement sans tatouage pour un meilleur confort du patient.
L'implémentation de ce système démontre l'engagement de Halifax Health à fournir des soins oncologiques de pointe à la communauté du comté de Volusia, pouvant améliorer les résultats des traitements et la qualité de vie des patients.
Halifax Health in Florida ist das erste Krankenhaus in den USA, das Krebspatienten mit dem Accuray Radixact®-System mit VitalHold™-Technologie behandelt. Dieses fortschrittliche System, das im Cancer Center for Hope – Port Orange untergebracht ist, kombiniert ClearRT® helikale CT-Bildgebung und Synchrony® Echtzeit-adaptive Liefertechnologien, um die Genauigkeit bei der Strahlenabgabe zu verbessern.
Die VitalHold-Funktion umfasst eine vollständig integrierte und automatisierte oberflächengeführte Radiotherapie (SGRT)-Lösung von C-RAD, die Vorteile wie eine hochpräzise Patientenpositionierung bietet und Behandlungen mit tiefem Inspirations-Atemhalt (DIBH) ermöglicht. Diese Technologie zielt darauf ab, die Strahlendosis für gefährdete Organe zu minimieren und unterstützt eine tattoofreie Positionierung für verbesserten Patientenkomfort.
Die Implementierung dieses Systems zeigt das Engagement von Halifax Health, der Gemeinschaft in Volusia County erstklassige Krebsbehandlungen anzubieten, was möglicherweise die Behandlungsergebnisse und die Lebensqualität der Patienten verbessert.
- First U.S. hospital to use Accuray Radixact® System with VitalHold™ technology for cancer treatment
- Enhanced precision in radiation delivery through advanced patient positioning capabilities
- Potential for faster and more effective radiotherapy treatments
- Ability to treat a wider range of cancer cases, including breast cancer
- Incorporation of surface-guided radiotherapy (SGRT) for highly accurate patient positioning
- Support for deep inspiration breath hold (DIBH) treatments to minimize radiation dose to organs at risk
- Tattoo-free positioning for improved patient comfort and potentially better cosmetic results
- None.
Insights
The introduction of the Radixact® System with VitalHold™ technology at Halifax Health marks a significant advancement in radiation therapy. This system's integration of surface-guided radiotherapy (SGRT) and deep inspiration breath hold (DIBH) techniques offers several key benefits:
- Enhanced precision in patient positioning and monitoring throughout treatment
- Potential reduction in radiation exposure to healthy tissues, particularly for breast cancer patients
- Improved patient comfort with tattoo-free positioning
While this technology shows promise in improving treatment accuracy and patient experience, its long-term clinical outcomes and cost-effectiveness remain to be seen. The system's ability to adapt to future innovations could prove valuable as cancer cases are projected to rise by
For Accuray (NASDAQ: ARAY), this milestone installation at Halifax Health could have positive implications:
- First-mover advantage in the U.S. market with this advanced technology
- Potential for increased market share in the competitive radiation therapy equipment sector
- Possible boost to revenue streams from both equipment sales and ongoing service contracts
However, investors should note that the financial impact may be gradual. The high cost of such systems typically limits rapid adoption and healthcare providers often have long procurement cycles. Additionally, Accuray's ability to scale production and support for this new technology will be important for capitalizing on its potential market opportunity.
New Technology Provides Advanced Patient Positioning Capabilities With the Radixact System, Making it Easier to Deliver Fast and Effective Radiotherapy Treatments
Halifax Health augmented its Radixact System with the Accuray proprietary ClearRT® helical CT imaging and Synchrony® real-time adaptive delivery technologies. The comprehensive radiotherapy delivery system, in combination with VitalHold, is designed to facilitate treatment of a wider range of cancer cases including breast cancer, faster and with less harm to patients.
"With the estimated number of new cancer cases in the
Ms. Winter continued, "We are proud to partner with the Halifax Health team as they continue to advance patient centered cancer care in
The VitalHold feature incorporates a fully integrated and automated surface-guided radiotherapy (SGRT) solution, Catalyst+ HD from C-RAD, on the Radixact System that offers multiple benefits for medical teams and their patients. SGRT is a technology that supports highly accurate positioning by scanning a patient's body surface with a high-resolution camera and reconstructing it as a 3D image in real-time. The reconstructed image enables clinicians to easily visualize the difference between the current body position and the target position, helping to ensure high reproducibility of the patient position during treatment.
In addition, VitalHold enables deep inspiration breath hold (DIBH) treatments on the Radixact System. During DIBH treatments, a patient takes a deep breath which moves the heart away from the chest wall and the targeted tumor to help minimize radiation dose to organs at risk (OARs) and reduce associated complications later in life. VitalHold DIBH treatments use SGRT to confirm the patient is appropriately positioned to deliver radiation. SGRT supports tattoo-free positioning, meaning no permanent markers are needed on the patient's skin to align the patient before radiation treatment delivery. Tattoo-free treatments increase patient comfort and potentially improve cosmetic results.
"As the first and only center in the
"We are delighted that the VitalHold solution has been chosen by the Halifax Health team. Equipping their Radixact® System with SGRT will support in serving the
About Halifax Health
Recognized as one of the 50 Top Cardiovascular Hospitals™ in
Important Safety Information
For Important Safety Information please refer to https://www.accuray.com/safety-statement.
About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in
Safe Harbor Statement
Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited to, expectations regarding the company's products and upgrades, market expectations, clinical applications, clinical results, patient experiences and patient outcomes. These forward-looking statements involve risks and uncertainties. If any of these risks or uncertainties materialize, or if any of the company's assumptions prove incorrect, actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the company's ability to achieve widespread market acceptance of its products, including new product innovations and releases; the company's ability to develop new products or improve existing products to meet customers' needs; the company's ability to anticipate or keep pace with changes in the marketplace; and the direction of technological innovation and customer demands and such other risks identified under the heading "Risk Factors" in the company's quarterly report on Form 10-Q, filed with the Securities and Exchange Commission (the "SEC") on May 8, 2024, and as updated periodically with the company's other filings with the SEC.
Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.
Media Contact:
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
John Guthrie
Vice President of Corporate Communications, Halifax Health
(386) 425-4372
john.guthrie@halifax.org
*VitalHold™ availability is subject to regulatory clearance or approval in some markets.
1 International Agency for Research on Cancer.
https://gco.iarc.fr/tomorrow/en/dataviz/bubbles?populations=840. Accessed on July 23, 2024.
View original content to download multimedia:https://www.prnewswire.com/news-releases/halifax-health-in-florida-is-first-in-the-us-to-treat-patients-with-cancer-using-the-accuray-radixact-radiation-delivery-system-and-vitalhold-technology-302220799.html
SOURCE Accuray Incorporated
FAQ
What is the Accuray Radixact® System with VitalHold™ technology?
How does VitalHold™ technology benefit cancer patients?
Which hospital is the first in the U.S. to use the Accuray Radixact® System with VitalHold™ technology?
What types of cancer can be treated with the Accuray Radixact® System with VitalHold™ technology?
How does the Accuray Radixact® System with VitalHold™ technology impact Accuray's (ARAY) market position?
